ADMA Biologics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ADMA | ABUS | ABCL | VERA | 301080.SZ | BHVN | |
|---|---|---|---|---|---|---|
| Market cap | 2.35B | 622.30M | 3.98B | 2.30B | 16.17B | 2.30B |
| P/E (TTM) | 15.0 | 5.1 | — | — | 83.1 | — |
| Forward P/E | 11.1 | -24.6 | -16.1 | -7.5 | — | -8.2 |
| Price/book | 5.2 | 3.1 | 4.2 | 5.6 | 5.9 | -23.4 |
| Dividend yield | — | — | — | — | 0.63% | — |
| 1-year change | −27.72% | −15.84% | +171.08% | +27.43% | +57.00% | +78.66% |
| Today | −5.67% | +4.64% | +0.82% | +4.10% | +1.77% | −2.37% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ADMA news ›Adma Biologics reiterates at least $530M 2026 revenue and raises minimum adjusted EBITDA to at least $275M as ASCENIV demand accelerates
ADMA Biologics Q3 2026 earnings: ASCENIV demand surged, margins expanded, and profit guidance rose. Earnings Call Insights: ADMA Biologics (ADMA) Q3 2026 - "Our third quarter performance highlights two key items. First, we are seeing…
ADMA Biologics, Inc. (ADMA) Q3 2026 Earnings Call Transcript
ADMA Biologics, Inc. (ADMA) Q3 2026 Earnings Call November 4, 2026 4:30 PM EST Adam Grossman - Co-Founder, President, CEO & DirectorP. Terence Kohler - CFO & Treasurer Ryan Deschner - Raymond James & Associates, Inc., Research…
Adma Biologics: Q3 Earnings Snapshot
RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported third-quarter profit of $49.9 million. On a per-share basis, the Ramsey, New Jersey-based company said it had profit of 22 cents. The infectious…
ADMA Biologics, Inc.(NasdaqGM: ADMA) added to Russell 2000 Defensive Index
ADMA Biologics, Inc. added to Russell 2000 Defensive Index... ADMA Biologics, Inc.(NasdaqGM:ADMA) added to Russell 2000 Defensive Index Latest news about ADMA Biologics, Inc. Chart ADMA Biologics, Inc. Income Statement and Estimates This…
ADMA Biologics, Inc. Reiterates Earnings Guidance for the Fiscal Year 2026
ADMA Biologics, Inc. reiterated earnings guidance for the fiscal year 2026. For the year 2026, the company expects total revenue expected to be $530 million to $560 million.... ADMA Biologics, Inc. Reiterates Earnings Guidance for the…
Tranche Update on ADMA Biologics, Inc.'s Equity Buyback Plan announced on May 7, 2025.
From January 1, 2026 to March 31, 2026, the company has repurchased 6,754,156 shares, representing 2.84% for $79.89 million. With this, the company has completed the repurchase of 8,673,226 shares,... Tranche Update on ADMA Biologics,…
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
No thromboembolic events, or blood-clot events, were reported for products made using the optimized process from July 1, 2025 through July 31, 2026. Evidence is limited by the three-lot sample and relatively short surveillance period.…
Adia Med Sells 30% of Adia Labs to QCM Biologics for $1.5 Million; Note and Option Included
TradingView Adia Med Sells 30% of Adia Labs to QCM Biologics for $1.5 Million; Note and Option Included Adia Med entered into a Membership Interest Purchase Agreement to sell 30% of Adia Labs to QCM Biologic
InMed Pharmaceuticals (NASDAQ:INM) Major Shareholder Adar1 Capital Management, Llc Acquires 18,182 Shares of Stock
Posted by Defense World Staff on Oct 6th, 2026 Adar1 Capital Management, Llc also recently made the following trade(s): INM stock opened at $1.33 on Tuesday. InMed Pharmaceuticals Inc. has a 52-week low of $0.57 and a 52-week high of…
MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway
Oct 06, 2026, 05:36 ET BFA Law is investigating whether Medline Inc. committed securities fraud relating to statements about Medline's manufacturing and product quality. NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Leading securities law firm…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com9
- seekingalpha.com2
- defenseworld.net1
- prnewswire.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.